Annora Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANNORA, and what generic and branded alternatives to ANNORA drugs are available?
ANNORA has thirty-six approved drugs.
There are five tentative approvals on ANNORA drugs.
Drugs and US Patents for Annora
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annora Pharma | MESALAMINE | mesalamine | SUPPOSITORY;RECTAL | 213377-001 | Mar 19, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | GABAPENTIN | gabapentin | SOLUTION;ORAL | 217682-001 | Jan 17, 2024 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | IVABRADINE HYDROCHLORIDE | ivabradine hydrochloride | TABLET;ORAL | 213366-002 | Oct 5, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.